Metabolic · Menopause
Insulin resistance in menopause: the hidden metabolic shift
Estrogen supports insulin sensitivity at muscle, liver, and adipose tissue. When estrogen drops, insulin resistance rises — even in women who eat the same and exercise the same. It shows up first as belly fat, mid-afternoon crashes, and rising fasting insulin. Glucose usually stays normal until later. Catching it early is the entire game.
Why estrogen matters metabolically
Estrogen enhances insulin receptor sensitivity, promotes glucose uptake in skeletal muscle, and shifts fat storage away from the visceral (abdominal) compartment. Its loss reverses all three.
The early warning signs
- New belly fat despite unchanged diet
- Mid-afternoon crashes and cravings
- Elevated fasting insulin with normal glucose
- Rising triglycerides, falling HDL
- Skin tags or acanthosis nigricans (velvety dark patches)
Treatment stack
- Transdermal estradiol
- Resistance training 3×/week
- Zone 2 cardio 150 min/week
- Protein-forward diet, minimize refined carbs
- Metformin or GLP-1 if lifestyle + HRT insufficient
- Sleep 7–8 hours (poor sleep worsens insulin resistance markedly)
Frequently asked questions
How do I test for insulin resistance?
Fasting insulin, fasting glucose, and HOMA-IR (calculated). HbA1c misses early insulin resistance. Ideal: fasting insulin <7, HOMA-IR <1.5.
Does HRT reverse insulin resistance?
Yes. Transdermal estradiol improves insulin sensitivity within 3–6 months. Oral estrogens are less favorable metabolically.
What lifestyle interventions work?
Resistance training (highest impact), zone 2 cardio, protein 1.2–1.6g/kg, reducing refined carbs, and sleep repair.
What about metformin or GLP-1s?
Metformin can help mild insulin resistance. GLP-1s (semaglutide, tirzepatide) address it directly and produce weight loss.
Is this the same as prediabetes?
Insulin resistance precedes prediabetes by 5–10 years. Prediabetes is defined by glucose numbers; insulin resistance shows up in fasting insulin first.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.